16:33 EDT Aslan Pharmaceuticals files to sell 61.9M ordinary shares for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASLN:
- Aslan Pharmaceuticals Amends Loan Conversion Terms
- ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
- Aslan Pharmaceuticals presents data on eblasakimab as ATS conference
- ASLAN Pharmaceuticals Excels in Eblasakimab Trials
- Aslan Pharmaceuticals reports Q1 EPS (53c) vs. ($1.29) last year